Total Payments
$2,942
2024 Payments
$25.69
Companies
17
Transactions
40
Medicare Patients
1,139
Medicare Billing
$371,057
Payment Breakdown by Category
Travel$1,708 (58.0%)
Food & Beverage$1,039 (35.3%)
Education$195.14 (6.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,708 | 3 | 58.0% |
| Food and Beverage | $1,039 | 34 | 35.3% |
| Education | $195.14 | 3 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $1,925 | 4 | $0 (2021) |
| AbbVie Inc. | $214.56 | 12 | $0 (2023) |
| Akcea Therapeutics, Inc. | $146.22 | 1 | $0 (2019) |
| GENZYME CORPORATION | $117.03 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $89.99 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $78.26 | 1 | $0 (2019) |
| Mallinckrodt LLC | $76.85 | 4 | $0 (2018) |
| NEUROPACE, INC. | $71.14 | 4 | $0 (2024) |
| SK Life Science, Inc. | $49.82 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $33.03 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.69 | 1 | NEUROPACE, INC. ($25.69) |
| 2023 | $274.01 | 16 | AbbVie Inc. ($194.98) |
| 2022 | $267.73 | 7 | GENZYME CORPORATION ($92.99) |
| 2021 | $1,997 | 6 | LivaNova USA, Inc. ($1,925) |
| 2019 | $243.57 | 3 | Akcea Therapeutics, Inc. ($146.22) |
| 2018 | $100.89 | 5 | Mallinckrodt LLC ($76.85) |
| 2017 | $33.03 | 2 | Novartis Pharmaceuticals Corporation ($33.03) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/12/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Epilepsy | ||||||
| 10/12/2023 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Epilepsy | ||||||
| 10/09/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Central Nervous System | ||||||
| 05/23/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Epilepsy | ||||||
| 04/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $73.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: CNS | ||||||
| 01/24/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Central Nervous System | ||||||
| 10/11/2022 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: CNS | ||||||
| 09/27/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Education | In-kind items and services | $92.99 | General |
| Category: Neurology | ||||||
| 08/23/2022 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Epilepsy | ||||||
| 05/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Education | In-kind items and services | $12.16 | General |
| Category: Migraine | ||||||
| 02/01/2022 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Neurology | ||||||
| 01/10/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Neuroscience | ||||||
| 12/08/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 461 | 18,003 | $367,541 | $134,555 |
| 2022 | 12 | 520 | 24,817 | $494,113 | $186,366 |
| 2021 | 6 | 158 | 6,753 | $118,485 | $50,135 |
Total Patients
1,139
Total Services
49,573
Medicare Billing
$371,057
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 50 | 17,400 | $157,934 | $83,401 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 182 | $60,883 | $15,936 | 26.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 49 | 82 | $31,470 | $8,912 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 109 | $25,664 | $6,118 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $26,350 | $5,893 | 22.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 21 | 21 | $20,709 | $5,583 | 27.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $13,691 | $3,839 | 28.0% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 18 | 42 | $15,716 | $3,180 | 20.2% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 18 | 42 | $14,747 | $1,459 | 9.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 19 | 40 | $377.20 | $234.09 | 62.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 49 | 24,100 | $223,889 | $117,546 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 153 | $51,182 | $13,472 | 26.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 49 | 120 | $46,054 | $12,777 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 89 | 89 | $38,445 | $9,837 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $25,100 | $6,664 | 26.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 22 | 22 | $21,695 | $6,220 | 28.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 16 | 16 | $18,718 | $5,475 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 83 | $19,542 | $5,036 | 25.8% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2022 | 23 | 55 | $19,947 | $4,160 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 22 | $10,277 | $2,963 | 28.8% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 23 | 55 | $18,718 | $1,936 | 10.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 24 | 58 | $546.94 | $280.45 | 51.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 22 | 6,600 | $60,588 | $33,077 | 54.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $21,599 | $6,299 | 29.2% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 22 | 33 | $12,665 | $3,810 | 30.1% |
About Rachel Brown
Rachel Brown is a Neurology healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1154775435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Brown has received a total of $2,942 in payments from pharmaceutical and medical device companies, with $25.69 received in 2024. These payments were reported across 40 transactions from 17 companies. The most common payment nature is "Travel and Lodging" ($1,708).
As a Medicare-enrolled provider, Brown has provided services to 1,139 Medicare beneficiaries, totaling 49,573 services with total Medicare billing of $371,057. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Bend, OR
- Active Since 04/22/2016
- Last Updated 04/11/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1154775435
Products in Payments
- VNS - Sentiva (Device) $1,925
- TEGSEDI (Drug) $146.22
- QULIPTA (Drug) $117.68
- AUBAGIO (Drug) $117.03
- UBRELVY (Drug) $96.88
- Ponvory (Drug) $89.99
- Soliris (Drug) $78.26
- ACTHAR (Biological) $76.85
- RNS Neurostimulator Kit (Device) $71.14
- XCOPRI (Drug) $49.82
- APTIOM (Drug) $38.52
- GILENYA (Drug) $33.03
- BOTOX (Biological) $22.73
- Epidiolex (Drug) $19.09
- ADUHELM (Biological) $17.39
- Austedo XR (Drug) $16.11
- AUSTEDO (Drug) $14.57
- Trudhesa (Drug) $12.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bend
Asha Singh, Md, MD
Neurology — Payments: $4,465
Neurology $4,465
Michael Bell, M.d, M.D
Neurology — Payments: $3,125
Neurology $3,125
Dr. David Schloesser, M.d, M.D
Neurology — Payments: $3,087
Neurology $3,087
Francena Abendroth, Md, MD
Neurology — Payments: $2,513
Neurology $2,513
Jeremiah Lanford, M.d, M.D
Neurology — Payments: $2,469
Neurology $2,469
Dr. Tyler Clark, M.d, M.D
Neurology — Payments: $1,331
Neurology $1,331